Kidney diseases articles within Nature

Featured

• Article | 11 November 2020

  Decoding myofibroblast origins in human kidney fibrosis

  A range of techniques are used to investigate the molecular landscape of chronic kidney disease, and the results suggest that distinct populations of pericytes and fibroblasts are the main source of myofibroblasts in kidney fibrosis.

  • Christoph Kuppe
  • , Mahmoud M. Ibrahim
  •  & Rafael Kramann

• Letter | 28 November 2018

  Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury

  AKR1A1-regulated protein S-nitrosylation protects against kidney injury through PKM2-mediated metabolic reprogramming.

  • Hua-Lin Zhou
  • , Rongli Zhang
  •  & Jonathan S. Stamler

• Letter | 08 August 2016

  Molecular modifiers reveal a mechanism of pathological crystal growth inhibition

  Like citrate, the molecule hydroxycitrate is shown to inhibit growth of the crystal that is the principal component of kidney stones, suggesting that hydroxycitrate could be another treatment for kidney stone disease.

  • Jihae Chung
  • , Ignacio Granja
  •  & Jeffrey D. Rimer

• News | 18 September 2012

  The hidden threat of West Nile virus

  Researchers probe possible link with kidney disease.

  • Amy Maxmen

• Letter | 22 January 2012

  Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities

  Exome sequencing identifies mutations in kelch-like 3 and cullin 3 as causes of a syndrome featuring high blood pressure and electrolyte abnormalities.

  • Lynn M. Boyden
  • , Murim Choi
  •  & Richard P. Lifton

• News | 10 May 2010

  Biomarkers for kidney damage should speed drug development

  Drug-safety indicators are the first fruits of a collaboration between academia, industry and regulators.

  • Brendan Borrell